Strengthening the Provision of Accessible and Quality Assured Laboratory Services in Namibia through the Namibia Institute of Pathology for Sustained Epidemic Control of HIV and TB under PEPFAR
The Award Ceiling for Year 1 is 0 (none).
CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,500,000 for Year 1, subject to the availability of funds.
Over the next five years, diagnostic network optimization (DNO) within the laboratory system will be the primary overarching activity since it pinpoints deficiencies and strengthens the identified gaps remaining to reach sustained epidemic control of HIV and TB in Namibia, as well as responds to outbreak needs as they occur.
Broadly, the activities under this NOFO will include:
1) the establishment of a national transport system using the Namibia Institute of Pathology (NIP) system as a base, 2) workflow analyses to assess testing needs based on number of patients on antiretroviral therapy (ART), 3) assessment of instrument utilization, and 4) establishment of a national unique patient identifier.
These activities will enable the country to better track patients from one viral load (VL) test to the next to ensure suppression rates are accurate for all patients on ART, enhance and expand infant diagnosis to greater than the current 80% coverage, and ensure that all HIV patients that are dually infected with TB are diagnosed and treated.
CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,500,000 for Year 1, subject to the availability of funds.
Over the next five years, diagnostic network optimization (DNO) within the laboratory system will be the primary overarching activity since it pinpoints deficiencies and strengthens the identified gaps remaining to reach sustained epidemic control of HIV and TB in Namibia, as well as responds to outbreak needs as they occur.
Broadly, the activities under this NOFO will include:
1) the establishment of a national transport system using the Namibia Institute of Pathology (NIP) system as a base, 2) workflow analyses to assess testing needs based on number of patients on antiretroviral therapy (ART), 3) assessment of instrument utilization, and 4) establishment of a national unique patient identifier.
These activities will enable the country to better track patients from one viral load (VL) test to the next to ensure suppression rates are accurate for all patients on ART, enhance and expand infant diagnosis to greater than the current 80% coverage, and ensure that all HIV patients that are dually infected with TB are diagnosed and treated.
Agency: Department of Health and Human Services
Office: Centers for Disease Control - CGH
Estimated Funding: $0
Office: Centers for Disease Control - CGH
Estimated Funding: $0
Obtain Full Opportunity Text:
https://www.hud.gov/program_offices/spm/gmomgmt/grantsinfo/fundingopps
Additional Information of Eligibility:
Eligible applicants that can apply for this NOFO are: Namibia Institute of Pathology (NIP)
Full Opportunity Web Address:
https://www.hud.gov/program_offices/spm/gmomgmt/grantsinfo/fundingopps
Contact:
Agency Email Description:
dln6@cdc.gov
Agency Email:
Date Posted:
2021-03-03
Application Due Date:
Archive Date:
2012-10-19
Social Entrepreneurship
Spotlight
Calgary Social Enterprise Offers High-Tech Services by People with Autism
Meticulon, a project of Autism Calgary Association in partnership with the federal government and the Sinneave Family Foundation, operates as a social enterprise that renders high-tech services provided by people with autism, leveraging their natural abilities at requiring attention to detail, repetition, and sequencing.
Learn How to Identify and Avoid Grant Scams
